http://www.law360.com/ Latest articles for organization: Apotex Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/135389 Exela PharmSci Pvt. Ltd. wants a federal appeals court to review a decision that the India-based drugmaker's proposed generic version of Allergan Inc.’s glaucoma treatment Alphagan infringed a patent. http://www.law360.com/articles/135389 http://www.law360.com/articles/133053 Allergan Inc. continues to pounce on rival drugmakers' attempts to market generic versions of Combigan, most recently accusing Alcon Inc. of infringing three patents for the glaucoma treatment. http://www.law360.com/articles/133053 http://www.law360.com/articles/132454 Shire LLC has settled yet another patent infringement suit involving Carbatrol, this time by granting Apotex Inc. a license that will allow it to sell its own generic version of the epilepsy drug. http://www.law360.com/articles/132454 http://www.law360.com/articles/131977 Calling the inquiries “irrelevant and inappropriate,” Sanofi-Aventis SA and Bristol-Myers Squibb Co. have sought to snuff out six subpoenas issued by generic-drug maker Apotex Inc. in connection with settlement amount determinations in a patent infringement dispute over blockbuster blood thinner Plavix. http://www.law360.com/articles/131977 http://www.law360.com/articles/131836 Apotex Inc.'s legal dispute with Sanofi-Aventis over blood-thinning drug Plavix has hit a dead end, with the U.S. Supreme Court refusing to hear the generic-drug maker's arguments over whether substances produced by so-called obvious-to-try experiments should be patentable. http://www.law360.com/articles/131836 http://www.law360.com/articles/131461 Sanofi-Aventis is seeking to protect its flagship cancer treatment drug Taxotere in a lawsuit against generics maker Sandoz Inc., alleging Sandoz's abbreviated new drug application with the U.S. Food and Drug Administration violates Sanofi's patents. http://www.law360.com/articles/131461 http://www.law360.com/articles/130656 Purdue Pharma LP has resolved a patent dispute with Apotex Inc. that was tied into the multidistrict litigation alleging Purdue engaged in sham patent infringement litigation to keep generic companies from making copycat versions of painkiller OxyContin. http://www.law360.com/articles/130656 http://www.law360.com/articles/130291 Eye care giant Alcon Research Ltd. is seeking to end generic-drug maker Apotex Inc.’s bid to manufacture a generic version of Alcon’s Travatan eye drops, saying Apotex’s abbreviated new drug application infringes five Alcon patents. http://www.law360.com/articles/130291 http://www.law360.com/articles/130210 A federal court ruled Friday that two generic-drug makers violated patents held by Allergan Inc. for glaucoma treatments using brimonidine. http://www.law360.com/articles/130210 http://www.law360.com/articles/128750 Sun India Pharmaceuticals Inc. has backed off from marketing generic tablets of the lucrative Alzheimer's drug Namenda, becoming the latest manufacturer to surrender to Forest Laboratories Inc. in an ongoing patent battle. http://www.law360.com/articles/128750 http://www.law360.com/articles/126342 Generic-drug maker Apotex Corp. has launched a new attack on Bristol-Myers Squibb Co. and Sanofi-Aventis' patent for blood-thinning drug Plavix, arguing in a new suit that it is unenforceable because Bristol-Myers and Sanofi breached a 2006 settlement with Apotex over the patent. http://www.law360.com/articles/126342 http://www.law360.com/articles/124772 Plaintiffs are seeking to obtain class status in a multidistrict litigation accusing Pfizer Inc. and its Warner-Lambert Co. subsidiary of using patent litigation to postpone generic competition for epilepsy treatment Neurontin. http://www.law360.com/articles/124772 http://www.law360.com/articles/124883 Eisai Co. Ltd. has asked a federal court to dismiss Apotex Inc.’s declaratory judgment action over four patents covering Eisai’s Alzheimer’s drug Aricept, arguing that Apotex is using the suit to try to jump ahead of competitors in the approval process to market the generic drug. http://www.law360.com/articles/124883 http://www.law360.com/articles/124466 A federal judge has refused to toss Bayer HealthCare LLC's patent infringement case against Norbrook Laboratories Ltd. over a generic animal drug application filed with the U.S. Food and Drug Administration for medication that treats bovine respiratory disease. http://www.law360.com/articles/124466 http://www.law360.com/articles/124327 A federal judge has scuttled pharmaceuticals giant Wyeth's request for an immediate temporary restraining order barring the U.S. Food and Drug Administration's approval for India-based Orchid Chemicals & Pharmaceuticals Ltd.'s generic version of Wyeth's intravenous antibiotic Zosyn. http://www.law360.com/articles/124327 http://www.law360.com/articles/112088 Ultimately, even evidence of commercial success with a demonstrated nexus to the claimed invention may still be insufficient to overcome a strong prima facie case of obviousness. But evidence of secondary considerations, including commercial success, should not be overlooked by patent applicants or patentees, as it may play an increasingly important role post-KSR, say Raymond R. Mandra, Erin Austin and Damond Vadnais of Fitzpatrick Cella Harper & Scinto. http://www.law360.com/articles/112088 http://www.law360.com/articles/110616 As more law firms and law departments make the move to electronic billing, corporate clients are finding they can use the systems for more than just catching improper billings. http://www.law360.com/articles/110616 http://www.law360.com/articles/123155 Apotex Inc. has appealed to a federal district court to redact purportedly sensitive information in a document from its Effexor patent dispute with Wyeth, saying its confidential business information is hanging out in the open. http://www.law360.com/articles/123155 http://www.law360.com/articles/122810 AstraZeneca Plc has asked a federal court for a ruling in its favor in a nearly 2-year-old patent infringement litigation the pharmaceutical giant has been pursuing against several generic-drug makers over its cholesterol drug Crestor. http://www.law360.com/articles/122810 http://www.law360.com/articles/122236 In a lawsuit remanded in light of Wyeth v. Levine, the executor of the estate of a woman who committed suicide after taking a generic form of the antidepressant Paxil has asked a court to force Apotex Inc. to provide information on all communications it had with the U.S. Food and Drug Administration relating to the drug. http://www.law360.com/articles/122236